In plain language
In 164 patients at 9 sites, robotic-assisted percutaneous coronary intervention (PCI) was technically successful in 98.8% with no device complications, and the primary operator's radiation exposure was 95.2% lower than at the table. Doses to other fluoroscopy team members were not reported.
At a glance
- Type of study
- Original research, Prospective cohort study
- Who was studied
- Interventional cardiologists, Patients
- Size
- n = 164 patients
- Summary based on
- the abstract
What it found
Radiation exposure for the primary operator at the robotic cockpit was far lower than at the traditional table position.
Key figures: 95.2% lower
Device technical success with the robotic system alone was achieved in nearly all patients.
Key figures: 162 of 164 patients (98.8%)
Clinical procedural success was high, with a small number of periprocedural non-Q-wave myocardial infarctions.
Key figures: 160 of 164 patients (97.6%); 4 (2.4%) non-Q-wave MI
No deaths, strokes, Q-wave myocardial infarctions or revascularizations occurred within 30 days.
Limits to keep in mind
Single-arm feasibility study without a randomized manual comparison group; the dose reduction applies only to the primary operator and the abstract gives no data on other fluoroscopy team members, who stay at the bedside.
Related research summaries
- First-in-human evaluation of a novel robotic-assisted coronary angioplasty system (2011, Prospective cohort study)
- Operator radiation burden and periprocedural outcomes in robotic-assisted versus manual percutaneous coronary intervention: a meta-analysis (2026, Meta-analysis)
- Radiation Exposure, Training, and Safety in Cardiology (2024, Narrative review)
- Ionizing Radiation in Interventional Cardiology and Electrophysiology (2019, Narrative review)
- Clinical Feasibility of Robotic-Assisted Endovascular Visceral Interventions (2026, Prospective cohort study)
How this summary was made
ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.
Prepared November 3, 2026.